Accession Number: | 0001209191-20-020509 |
Date: | 2020-03-19 |
Issuer: | OUTLOOK THERAPEUTICS, INC. (OTLK) |
Original Submission Date: |
HADDADIN YEZAN MUNTHER
C/O OUTLOOK THERAPEUTICS, INC.
7 CLARKE DRIVE
CRANBURY, NJ 08512
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 0.54 | 2020-03-19 | deemed execution date | A | 15,000 (a) | 2030-03-19 | common stock 15,000 | $0.54 | 15,000 | direct |
ID | footnote |
---|---|
f1 | the options were granted under the issuer's 2015 equity incentive plan (the "2015 plan") and shall vest in full on march 19, 2021, subject to the reporting person providing continuous service to the issuer on such date and subject to acceleration upon a change in control as defined in the 2015 plan, subject to the reporting person providing continuous service to the issuer through such event. |